Chapter Outlines

Chapter 12      Influenza Viruses

[View Chapter Outlines list]
12.1 History
  • Influenza has been described as early as 400 B.C.
  • Major epidemics and pandemics of influenza have occurred in history.
  • Man virologists think another influenza pandemic that could kill millions of humans is inevitable.
12.2 Epidemiology
  • Epidemics become unmanageable at alarming speeds because:
    • Short incubation period (1-4 days)
    • One droplet can contain 100,000 to 1,000,000 virus particles!
    • Symptomatic people do not stay home = spread!
    • Lack of herd immunity
  • Absenteeism form schools is the best indicator of the scale of an epidemic.
Influenza Statistics
  • 1957-1987: there were 20 influenza epidemics recorded in the U.S.
  • 36,000-50,000 people have died as a direct or indirect consequence of an influenza infection
The 1918 Influenza Pandemic
  • Also called the Spanish flu
  • Killed 675,000 Americans
  • 4.39/1000 national average
  • Death rates peaked in October of 1918
  • Unique epidemic: healthy adults ages 20-40 died of the flu, in addition to children and elderly (who are usually high-risk)
  • It decreased the life expectancy in the U.S. by 11 years.
12.3 Clinical Features of Influenza: Uncomplicated Infection
  • Onset of symptoms:
    • Headache
    • Aching in the limbs and back
    • Fever (100-103 oF)
    • Malaise
    • Dry cough
    • Tickling throat
    • Sore throat
    • Myalgia
    • Chest X-ray is normal
  • Usually resolves itself after 7 days
Influenza: Complicated Infection
  • Age-dependent
  • Young children: croup, secondary bacterial pneumonia, middle ear infections
  • Elderly: life threatening secondary bacterial pneumonia, pre-existing conditions like congestive heart disease exacerbated
  • Immune compromised individuals: at risk of death duirng an influenza epidemic
Reye's Syndrome
  • Rare condition
  • Risk of developing Reye's Syndrome (R.S.) increases with aspirin use
  • R.S. affects all organs of the body
  • Most harmful to brain and liver
  • Causes pressure in the brain and massive accumulation of fat in the liver and other organs
12.4 Classification of Influenza Viruses
  • Orthomyxoviridae family
  • 3 Types of Influenza: A, B and C
  • All 3 can infect and cause similar symptoms in humans
  • Infection with one type does not confer immunity to another type of influenza
12.5 Laboratory Diagnosis
  • Office-based rapid tests - ELISA assays
    • Some can distinguish between Influenza A and B
    • Fast results - 1- to 20 minutes
    • Some false-positive or negative results
  • Other Tests
    • Cell Culture: inoculate MDCK cells, most accurate test
  • Serology
    • Analyze convalescent serum and analyze for an increase in antibody titer
  • "Flu chips" or microarrays
12.6 Cellular Pathogenesis
  • Droplet transmission
  • Virus enters respiratory tract
  • Attaches to ciliated columnar epithelial cells lining the sinuses and airways
  • Primary site of infection - tracheobronchial tree, involving nasopharynx
  • As virus replicates, cilia are destroyed
    • Cleaning of the lungs system does not work as well
    • More mucus stays in the airway, clogging them, causing coughing
  • Destruction of cilia contribute to secondary bacterial pneumonia infections, sinusitis, otitis
12.7 Immunity
  • Infected individuals develop antibodies against the outer proteins of Influenza virus - neuraminidase (N) and hemagglutinin (H)
  • Antibodies against H neutralize the virus
  • Antibodies against N do not but they do reduce the release of virus from infected cells
  • If a person has been infected in the past couple of years by a closely related strain of influenza H subtype -
    • Their antibodies may intercept and neutralize the virus, protecting the lungs.
Cytokine Storm
  • Also referred to as systemic inflammatory response syndrome (SIRS).
  • SIRS may explain the devastating nature of the 1918 strain of influenza.
  • The immune system overreacts toward the pathogen.
  • Cytokines signal macrophages to travel to the site of infection, causing damage to the body and organ failure.
  • H5N1 Avian Influenza virus also causes SIRS and is at least 50% lethal in humans.
12.8 Viral Replication
  • Properties of the Influenza A Particle
    • Immediately after isolation, particles are filamentous.
    • After several passages in cell cultures, the particles become spherical.
Influenza A Virus Particle
  • Enveloped
  • Contains hemagglutinin (H) antigen glycoprotein spikes on the surface and neuraminidase (N) antigen spikes.
  • M2 ion channel protein
  • 8 segments of ssRNA of negative polarity
Virus Nomenclature
  • Influenza type/
  • Species isolated form (unless human)
  • Place of Isolation
  • Strain designation
  • Year isolation
  • H#N# subtypes
  • Example: A/Hong Kong/1/68(H3N2)
Influenza A Life Cycle
  • Influenza virus H binds to sialic acid present on glycoproteins of ciliated cells lining the sinuses and airways.
  • Virions enter by endocytosis.
  • Inside of the endosome, the virion is exposed to a low pH (from 7 to 5).
  • The low pH causes H to undergo a conformational change
H protein
  • Must be cleaved by cellular proteases inside of the trans golgi network for the virus to be infectious.
Influenza A Uncoating Step
  • M2 ion channel in the viral envelop allows H+ ions to penetrate the virion,
  • Weakens the viral M1 matrix protein from the viral RNA, NP, and transcriptase complex (RNP)
  • RNPs released into the cytoplasm
  • Amantidine (sold as Symmetrel) and rimantidine (sold as Flumadine) block the M2 ion channel function, interfering with uncoating.
mRNA Synthesis and Replication of Virion RNA
  • After the viral RNPs enter the nucleus, mRNA synthesis begins
  • Cap-snatching process
    • Viral PB2 protein binds to the cap structure along with a short string of nucleotides of host mRNA in the nucleus of the cell.
Viral mRNAs are not Cannibalized for Their 5' Caps
  • The viral PB2 polymerase proteins selectively "snatch" caps.
  • Binds to a specific sequence that is complementary to nucleotides 1-12 of the 3' ends of each vRNA segment.

Influenza Exploits Host - Nuclear-Splicing Machinery to Splice Viral mRNA Segments 7 and 8

NS1 Prevents Nuclear Export of Cellular Pre-mRNAs, Facilitating Cap-Snatching
Translational Control Mechanisms
  • Influenza A suppresses the interferon system in host cells.
Virion Maturation and Assembly
  • Capped mRNAs exported to nucleus are translated by ribosomes in the cytoplasm
  • H, N, and M2 are folded and glycosylated and transported to the trans Golgi network and cell surface where assembly takes place.
  • One copy of each genome segment is packaged into the virion.
Release of Influenza Virions
  • Virions are released by budding.
  • The viral N protein cleaves the sialic acid on host cells to prevent clumping of viral particles at the host surface.
  • Zamanivir (sold as Relenza) and oseltamivir phosphate (sold as Tamiflu) inhibit the function of N.
12.9 Genetic Variation
  • Mutations are common during viral replication.
  • Viral RNA dependent RNA polymerase lacks proofreading and correction ability.
Two processes, antigenic drift and antigenic shift mediate genetic variation that causes new strains of influenza to appear.
  • Antigenic Drift - Season Influenza Strains
  • Antigenic Shift - Responsible for Pandemic Strains

Influenza Reassortments
Is China the Incubator for Flu Viruses?
  • Close association with humans with animals and birds.
  • Influenza A is constantly circulating in birds, pigs and horses.
Why is Influenza More Prevalent - During the Winter?
  • Aerosol spread of influenza virus is dependent upon humidity and temperature.
  • The virus was best transmitted at low humidity (20%) and colder temperatures (5 oC or 41oF).
  • Supporting evidence that weather conditions play a role in influenza virus transmission.
  • Lowen, A. C. et al. 2007. "Influenza Virus Transmission is Dependent on Relative Humidity and Temperature." PloS Pathogens 3(10):1470-1476.
12.10 Pandemics in History
The 1918 Spanish Flu Stats
  • Killed more people in 25 weeks than AIDS killed in 25 years.
  • Kill more people in a year than the plagues of the Middle Ages killed in a century.
  • Estimated deaths - 20 to 50 million, including 675,000 Americans.
  • In NYC, 21,000 children were orphaned by influenza.
  • 7 times as many people died of the 1918 Spanish Flu than in WWI.
  • True estimates will never be known.
It's Effects were Unique
  • It killed 20-40 year old adults.
  • It killed quickly (2-3 days).
  • Infected individuals suffered from hemorrhagic symptoms.
Why was the 1918 Spanish Flu So Deadly?
  • Johan Hultin exhumed bodies of flu victims buried in frozen ground at Brevig Mission, Alaska.
  • Removed frozen lung tissues and provided them to Jeffrey Taubenberger (Armed Forces Institute of Pathology in Washington D. C.) who sequenced the viral genome of the 1918 strain.
  • 1918 was an avian - not swine strain!
1918 Influenza Strain was Re-Created in the Laboratory, 2005
  • Terrence Tumpey, CDC researcher.
  • Reverse genetics.
  • Work done in an enhanced BSL-3 laboratory.
2007 Yoshihiro Kawaoka - University of Wisconsin-Madison
  • Infected macaques with the reconstructed 1918 Influenza virus.
  • Carried out experiments in a BSL-4 laboratory
  • Macaques died of SIRS (cytokine storm)
1957 Asian Flu
  • 70,000 Americans died.
  • Asian flu first identified in northern China (February, 1957) and spread to the U.S. by June, 1957.
  • Vaccine was made and available by August, 1957.
1968 Hong Kong Flu
  • First detected in Hong Kong during early months of 1968.
  • Reached the U.S. by September, 1968.
  • Deaths in the U.S. peaked in December, 1968-January, 1969 (mostly elderly).
  • Mildest pandemic in the century, killing only 33,800 people in the U.S.
  • 12.11 The Pandemic Scares
    1976 Swine Flu Scare: A/New Jersey/76/H1N1
    • February, 1976 Cadets at Fort Dix, NJ came down with the flu, one private died.
    • CDC investigated the outbreak.
    • 4 out of 19 throat washings tested positive for H1N1 influenza A (at the time believed to be a "swine" flu closely related to the 1918 Spanish flu virus).
    • 150 million doses of vaccine prepared in the U.S.
    • 46 million doses were administered within a few months.
    1976 Swine Flu Vaccine
    • Vaccine was fast-tracked
    • Congress passed a liability protect bill to protect manufacturers of the vaccine
    • Early problems of the vaccine:
      • Guillain Barre Syndrome (532 people within 10 weeks)
      • 32 deaths
    • Vaccine campaign suspended in the late fall of 1976
    • U. S. government paid more than $90 million on claims cases.
    1977 Russian Flu Scare: A/USSR/77/H1N1
    • May, 1977 Influenza A H1N1 isolated in northern China.
    • Primarily children and younger adults became ill.
    • This strain was similar to the 1957 strain
      • Individuals born before 1957 would have no cross-reacting/partial immunity toward the virus.
    1997 Avian Flu Scare: H5N1
    • May, 1997, 3 year old boy in Hong Kong died.
    • Influenza A isolated from the boy but the H subtype could not be identified.
      • Later confirmed to be H5
      • H5 not known to infect humans before (subtype isolated from birds only)
    • The "jump" of an avian strain directly to humans had never happened before.
    • Same H5N1 strain was killing chickens.
    1997 Hong Kong H5N1 Scare
    • Veterinary authorities slaughtered chickents to prevent the spread of H5N1 to chickens and people!
    Lessons Learned from the 1997 H5N1 Hong Kong Flu
    • Only 18 human cases in 1997
    • 33% fatality rate! (1918 flu was about 4% fatal in the U.S.)
    Avian Strains Continue to Plague Eastern Asia 12.12 Antivirals for Influenza Treatment
    • First drugs: M2 inhibitors (prevent uncoating step)
      • Amantidine (sold as Symmetrel)
      • Rimantidine (sold as Flumadine)
    • New class of antivirals: N inhibitors (prevents neuraminidase from cleaving sialic acid during budding)
      • Causes viruses to clump at the cell surface, reducing viral spread
      • Oseltamivir (sold as Tamiflu, pill form)
      • Zanamivir (sold as Relenza, must be inhaled)
    • Treatment must begin within 36 hours of onset of symptoms
    • Used prophylactically in chronic care facilities
    12.13 Influenza Vaccines - Against Seasonal Flu Strains
    • Most effective way to prevent influenza
    • Flu vaccination time in the U.S.: October and November
    • Vaccine grown in eggs
    • Inactivated trivalent vaccine
    • Live, attenuated vaccine, LAIV
      • Licensed in 2003
      • Only approved for healthy people ages 5-49 years
    Trivalent Vaccine Composition
    • Recommendations made based on antigenic analyses of recently isolated influenza viruses, epidemiologic data and post-vaccination serologic studies in humans
    • Vaccine is a cocktail of 3 virus strains
      • 2 strains of Influenza A
      • 1 Influenza B strain
    Effectiveness of the Vaccine
    • Age of the vaccine recipient
    • Immunocompetence of the recipient
    • Degree of similarity between the viruses in the vaccine and those in circulation
    Target Groups for Vaccination
    • Persons aged 50 or older
    • Individuals in chronic care facilities; including nursing homes
    • Individuals with pre-existing chronic problems
      • Asthma
      • other pulmonary or cardiovascular problems
      • immunosuppression
    • Children on long-term aspirin therapy
    • Pregnant women
    • Healthcare workers
    • Travelers
    12.14 International Influenza Surveillance
    • 1946 WHO established influenza surveillance program
    Influenza Sentinel Physicians in the United States
    • U.S. sentinel physicians send flu statistics to the CDC
    • Patient visits for influenza-like illness
    • Age groups
    • Morbidity and mortality stats
    Will There Be Another Killer Flu?: Are We Preparing?
    • Virologists say it is inevitable
    • Many pandemic planning teams at the international, national, state and local levels
    Will the Current Arsenal of Influenza Antivirals Work Against New Pandemic Strains of Influenza?
    • Tumpey 2002 study says yes.
    • Viral resistance has been shown.
    • We won't know until it happens.
    12.15 Lessons Learned from the SARS Outbreak of 2003
    • Within 6 weeks of its discovery:
      • SARS CoV infected thousands of people in 16 countries around the world.
    • Spread quickly by air travel.
    • Identification of pandemic strains and rapid response to contain outbreaks are paramount.

    Back to jbpub.com